Canton Strategic Holdings (CNTN) Enterprise Value (2020 - 2026)
Canton Strategic Holdings (CNTN) posted Enterprise Value of -$41.5 million for Q1 2026, down 143.84% on a QoQ basis from -$17.0 million in Q4 2025, and down 3760.12% year-over-year from $1.1 million in Q1 2025.
Canton Strategic Holdings (CNTN) Enterprise Value (2020 - 2026) Analysis & Trends
Canton Strategic Holdings' Enterprise Value history runs 7 years deep, the most recent figure standing at -$41.5 million for Q1 2026.
- Quarterly Enterprise Value fell 3760.12% year-over-year to -$41.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$41.5 million (down 3760.12% YoY) and the FY2025 annual result came in at -$17.0 million, down 378.53% from the prior year.
- Enterprise Value was -$41.5 million for Q1 2026 at Canton Strategic Holdings, down from -$17.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.1 million in Q1 2025 and bottomed at -$41.5 million in Q1 2026.
- A 5-year average of -$8.8 million and a median of -$7.6 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value tumbled 149361.29% — and 2025, when it soared 87.23%.
- Canton Strategic Holdings' Enterprise Value stood at -$6.5 million in 2022, then sank by 67.96% to -$10.9 million in 2023, then surged by 67.45% to -$3.6 million in 2024, then sank by 378.53% to -$17.0 million in 2025, then slumped by 143.84% to -$41.5 million in 2026.
- Business Quant data shows CNTN's Enterprise Value at -$41.5 million in Q1 2026, -$17.0 million in Q4 2025, and -$7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | -41.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.53 Mn |
| Dec 31, 2025 | -17.03 Mn |
| Sep 30, 2025 | -7.61 Mn |
| Jun 30, 2025 | -2.24 Mn |
| Mar 31, 2025 | -1.08 Mn |
| Dec 31, 2024 | -3.56 Mn |
| Sep 30, 2024 | -4.77 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -8.43 Mn |
| Dec 31, 2023 | -10.94 Mn |
| Sep 30, 2023 | -2.69 Mn |
| Jun 30, 2023 | -3.90 Mn |
| Mar 31, 2023 | -3.57 Mn |
| Dec 31, 2022 | -6.51 Mn |
| Sep 30, 2022 | -7.60 Mn |
| Jun 30, 2022 | -9.48 Mn |
| Mar 31, 2022 | -11.12 Mn |
| Dec 31, 2021 | -4,356.00 |
| Sep 30, 2021 | -45,095.00 |
| Jun 30, 2021 | -29,271.00 |